Medico Remedies Ltd Stock Price Today (NSE: MEDICO)
Fundamental Score
Medico Remedies Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medico Remedies Ltd share price today is ₹47.47, down 0.27% on NSE/BSE as of 19 June 2026. Medico Remedies Ltd (MEDICO) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹431.60 (Cr). The 52-week high for MEDICO share price is ₹56.88 and the 52-week low is ₹30.22. At a P/E ratio of 38.03x, MEDICO is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 17.57% and a debt-to-equity ratio of 0.19.
Medico Remedies Ltd Share Price Chart — NSE/BSE Historical Performance
Medico Remedies Ltd share price chart: 18.92% return over the past month. 52-week high ₹56.88, 52-week low ₹30.22.
Medico Remedies Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹47.63 | ₹48.79 | ₹46.71 | ₹47.47 | 88.89K (Cr) | |
| ₹47.17 | ₹50.90 | ₹47.17 | ₹47.60 | 4.50L (Cr) | |
| ₹49.32 | ₹49.32 | ₹47.21 | ₹47.67 | 2.03L (Cr) | |
| ₹48.96 | ₹48.96 | ₹48.96 | ₹48.96 | 0.00 (Cr) | |
| ₹48.22 | ₹50.00 | ₹47.20 | ₹48.96 | 8.50L (Cr) | |
| ₹49.24 | ₹49.90 | ₹47.59 | ₹48.27 | 5.40L (Cr) | |
| ₹48.00 | ₹49.80 | ₹46.85 | ₹49.24 | 6.91L (Cr) | |
| ₹47.45 | ₹48.60 | ₹46.00 | ₹47.84 | 4.45L (Cr) | |
| ₹46.60 | ₹48.00 | ₹45.00 | ₹47.12 | 3.68L (Cr) | |
| ₹45.00 | ₹46.70 | ₹43.78 | ₹45.96 | 5.80L (Cr) |
Medico Remedies Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹47.17 | ₹50.90 | ₹46.71 | ₹47.47 | +0.64% | |
| ₹41.10 | ₹50.00 | ₹39.12 | ₹47.67 | +15.99% | |
| ₹32.95 | ₹43.00 | ₹32.95 | ₹42.48 | +28.92% | |
| ₹41.10 | ₹45.00 | ₹30.22 | ₹32.76 | -20.29% | |
| ₹49.03 | ₹51.00 | ₹43.91 | ₹44.53 | -9.18% | |
| ₹50.92 | ₹54.24 | ₹44.32 | ₹50.88 | -0.08% | |
| ₹53.15 | ₹56.88 | ₹48.50 | ₹50.60 | -4.80% | |
| ₹49.37 | ₹54.30 | ₹46.87 | ₹52.11 | +5.55% | |
| ₹48.48 | ₹53.00 | ₹46.05 | ₹50.45 | +4.06% | |
| ₹38.23 | ₹49.15 | ₹38.10 | ₹48.21 | +26.11% | |
| ₹40.32 | ₹43.04 | ₹37.18 | ₹38.23 | -5.18% | |
| ₹42.00 | ₹45.45 | ₹37.46 | ₹40.19 | -4.31% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medico Remedies Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medico Remedies Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDICO across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (17.57%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.31%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (65.81%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (33.77%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Excellent EPS Growth (43.93% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (43.99% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (12.71x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.38%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-22.06 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.31%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medico Remedies Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Medico Remedies Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medico Remedies LtdMedico Remedies...Selected✓ MEDICO • 540937 | 64.8/100 | ₹47.47₹47 | ₹431.60₹431.60 | 38.03Average 38.0 Average | 17.57%Good 17.57% Good | 21.31%Excellent 21.31% Excellent | 0.19Excellent 0.2 Excellent | 43.99%Excellent 43.99% Excellent | 11.23%Good 11.23% Good | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Medico Remedies Ltd PE Ratio History
Historical price-to-earnings ratio for MEDICO — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.22 | ₹50.60 | 41.5x |
| FY 2024 | ₹1.00 | ₹54.95 | 55x |
| FY 2023 | ₹0.87 | ₹83.80 | 96.3x |
| FY 2022 | ₹0.58 | ₹65.17 | 112.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Medico Remedies Ltd Quarterly Performance
Latest quarterly metrics for MEDICO — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
33.77%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
65.81%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
11.23%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
43.99%
Compounded annual net profit growth over 5 years
Medico Remedies Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDICO — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Medico Remedies Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Medico Remedies Ltd (MEDICO) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Medico Remedies Ltd
About MEDICO (Medico Remedies Ltd)
Medico Remedies Ltd is a dynamic pharmaceutical company deeply rooted in the Indian healthcare landscape. It distinguishes itself through a multifaceted approach, spanning the enti...re value chain from meticulous product development to state-of-the-art manufacturing and strategic marketing. The company is driven by a commitment to improving patient well-being, evidenced by its consistent efforts to formulate effective and accessible pharmaceutical solutions. Operating with unwavering ethical standards, Medico Remedies cultivates strong relationships with healthcare professionals and distribution partners. This dedication to quality and reliability has earned them a trusted reputation within the pharmaceutical sector. They are continually striving to expand their portfolio, incorporating innovative therapies while maintaining a steadfast focus on affordability and accessibility for the Indian population. The company's diverse product portfolio reflects its comprehensive approach to healthcare. It encompasses a wide range of therapeutic categories, including treatments for prevalent conditions such as infections, cardiovascular ailments, and diabetes. They offer an extensive range of anti-infectives addressing bacterial, fungal, and parasitic infections. Complementing these are a variety of medicines targeting common ailments, such as pain relief, fever reduction, and digestive issues. Their dedication to holistic wellness extends to the development and distribution of essential vitamins and supplements, promoting preventative care and overall health. Medico Remedies also addresses neurological and mental health concerns through their line of antidepressants, antipsychotics and anti-epileptics. This comprehensive approach demonstrates their commitment to fulfilling diverse healthcare needs within the Indian market. Medico Remedies employs cutting-edge manufacturing processes to produce high-quality pharmaceutical formulations. Their modern facilities adhere to stringent quality control standards, ensuring that every product meets the highest levels of safety and efficacy. Their distribution network is strategically designed to reach both urban and rural areas across India, making their medicines accessible to a broad spectrum of the population. The company invests significantly in research and development, continuously exploring new therapeutic avenues and striving to improve existing formulations. They operate with a clear vision: to be a leading provider of reliable and affordable healthcare solutions, empowering individuals to lead healthier and more fulfilling lives.
Company Details
Key Leadership
Latest News
MEDICO Share Price: Frequently Asked Questions
What is the current share price of Medico Remedies Ltd?
Medico Remedies Ltd (MEDICO) trades at ₹47.47 on NSE and BSE. Market cap ₹431.60 (Cr). Educational data only.
What is the P/E ratio of Medico Remedies Ltd?
Medico Remedies Ltd has a P/E of 38.03x vs industry average 31.77x.
What is the Bull Run score for Medico Remedies Ltd?
Medico Remedies Ltd has a Bull Run score of 64.8/100 based on 25+ financial parameters.
Does Medico Remedies Ltd pay dividends?
Medico Remedies Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medico Remedies Ltd?
Medico Remedies Ltd has ROE of 17.57%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medico Remedies Ltd?
Medico Remedies Ltd has debt-to-equity of 0.19.
Is Medico Remedies Ltd a good investment?
Bull Run gives Medico Remedies Ltd a score of 64.8/100. This is not investment advice — consult a SEBI-registered advisor.